CLINICAL_TRIALS trial_result · 2018-06-11

Clinical Trial Update: An Open Label Study for Participants With Rheumatoid Arthritis [Phase 3]

This is an open-label Phase 3 trial in rheumatoid arthritis sponsored by Eli Lilly. The study was terminated, and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2018-06-11